Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Buy
58
CME Quote, Financials, Valuation and Earnings
Last price:
$232.73
Seasonality move
:
5.73%
Day range:
$232.10 - $235.75
52-week range:
$190.70 - $249.02
Dividend yield:
4.47%
P/E ratio:
24.47x
P/S ratio:
13.85x
P/B ratio:
2.97x
Volume:
1.9M
Avg. volume:
2.2M
1-year change:
14.65%
Market cap:
$83.9B
Revenue:
$5.6B
EPS (TTM):
$9.51
Analysts' Opinion
-
Consensus RatingCME Group has received a consensus rating of Hold. The company's average rating is a Hold based on 4 Buy ratings, 10 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $243.44, CME Group has an estimated upside of 4.61% from its current price of $232.71.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $190.00 representing 18.35% downside risk from its current price of $232.71.
Fair Value
-
According to the consensus of 14 analysts, CME Group has 4.61% upside to fair value with a price target of $243.44 per share.
CME vs. S&P 500
-
Over the past 5 trading days, CME Group has underperformed the S&P 500 by -1.34% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
CME Group does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
CME Group has grown year-over-year revenues for 13 quarters straight. In the most recent quarter CME Group reported revenues of $1.6B.
Earnings Growth
-
CME Group has grown year-over-year earnings for 2 quarters straight. In the most recent quarter CME Group reported earnings per share of $2.50.
Enterprise value:
84.9B
EV / Invested capital:
--
Price / LTM sales:
13.85x
EV / EBIT:
18.40x
EV / Revenue:
14.04x
PEG ratio (5yr expected):
1.81x
EV / Free cash flow:
23.39x
Price / Operating cash flow:
23.08x
Enterprise value / EBITDA:
17.14x
Gross Profit (TTM):
$5.2B
Return On Assets:
2.67%
Net Income Margin (TTM):
57.34%
Return On Equity:
12.57%
Return On Invested Capital:
11.18%
Operating Margin:
64.64%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $5B | $5.3B | $6B | $1.3B | $1.6B | |
| Gross Profit | $4.2B | $4.5B | $5.2B | $1.1B | $1.4B | |
| Operating Income | $3B | $3.2B | $3.8B | $820.2M | $1B | |
| EBITDA | $4B | $4.5B | $5B | $1.1B | $1.3B | |
| Diluted EPS | $7.35 | $8.38 | $9.51 | $2.06 | $2.50 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $90.3B | $151.6B | $143.3B | $90.8B | $103.1B | |
| Total Assets | $125.8B | $186.8B | $178.4B | $125.6B | $137.8B | |
| Current Liabilities | $88.6B | $150.4B | $140.6B | $87.9B | $100.8B | |
| Total Liabilities | $98.7B | $159.5B | $150.2B | $97.4B | $109.6B | |
| Total Equity | $27B | $27.3B | $28.3B | $28.2B | $28.2B | |
| Total Debt | $3.4B | $3.4B | $3.4B | $3.4B | $3.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.7B | $3.4B | $3.7B | $856.7M | $1B | |
| Cash From Investing | -$396.5M | $15.6M | -$77.7M | -$19.5M | -$29.5M | |
| Cash From Financing | -$10.9B | -$56B | $8.6B | -$26.5B | $13.3B | |
| Free Cash Flow | $2.7B | $3.3B | $3.6B | $836.8M | $973.2M | |
CME
Sector
Market Cap
$83.9B
$675.6M
Price % of 52-Week High
93.45%
88.53%
Dividend Yield
4.47%
2%
Shareholder Yield
--
3.89%
1-Year Price Total Return
14.65%
9.76%
Beta (5-Year)
0.560
0.738
Dividend yield:
4.47%
Annualized payout:
$9.65
Payout ratio:
102.88%
Growth streak:
5 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$229.95
200-day SMA
Buy
Level
$215.33
Bollinger Bands (100)
Buy
Level
218.31 - 234.53
Chaikin Money Flow
Buy
Level
295.3M
20-day SMA
Sell
Level
$232.85
Relative Strength Index (RSI14)
Buy
Level
50.89
ADX Line
Sell
Level
35.1
Williams %R
Neutral
Level
-27.3136
50-day SMA
Buy
Level
$232.40
MACD (12, 26)
Sell
Level
-0.97
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
351.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.6553)
Sell
CA Score
(Annual)
Level (-1.8091)
Buy
Beneish M-Score
(Annual)
Level (-2.2272)
Sell
Momentum Score
Level (6)
Buy
Ohlson Score
Level (0.3063)
Buy
Piotroski F Score
(Annual)
Level (8)
Sell
Quality Ratio Score
Level (1)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME’s acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.
Stock Forecast FAQ
In the current month, CME has received 4 Buy ratings 10 Hold ratings, and 0 Sell ratings. The CME average analyst price target in the past 3 months is $243.44.
-
Where Will CME Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that CME Group share price will rise to $243.44 per share over the next 12 months.
-
What Do Analysts Say About CME Group?
Analysts are divided on their view about CME Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that CME Group is a Sell and believe this share price will drop from its current level to $190.00.
-
What Is CME Group's Price Target?
The price target for CME Group over the next 1-year time period is forecast to be $243.44 according to 14 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 10 analysts rate the stock a Hold.
-
Is CME A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for CME Group is a Hold. 10 of 14 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of CME?
You can purchase shares of CME Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase CME Group shares.
-
What Is The CME Group Share Price Today?
CME Group was last trading at $232.73 per share. This represents the most recent stock quote for CME Group. Yesterday, CME Group closed at $232.71 per share.
-
How To Buy CME Group Stock Online?
In order to purchase CME Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is American Express Stock Going Lower?
American Express Company (NYSE:AXP) has long been a Buffett favorite…
Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
